Biomarkers in inflammatory bowel disease: current practices and recent advances.

Iskandar, Heba N., Ciorba, Matthew A.·2012·Translational Research
DOI 10.1016/j.trsl.2012.01.001

Cited by (210)

Items 201–210 of 210

  1. The Relationship Between Endoscopic Findings and Laboratory Results in Inflammatory Bowel Diseases
    Mehtap Şahin, Nihat Okçu · 2024 · Hitit Medical Journal
  2. Challenges and future directions in biomarker development
    Ekta Khare · 2025 · Elsevier eBooks
  3. OTOİMMÜN HASTALIKLARDA GLİKAN BİYOBELİRTEÇLERİN KEŞFİ: TANI VE TEDAVİDE SON GELİŞMELER
    Müşerref Çağlı, Rafig Gurbanov, İsmail Poyraz · 2025 · İstanbul Ticaret Üniversitesi Fen Bilimleri Dergisi
  4. Network pharmacology and molecular docking of Nelumbo nucifera Gaertn. to reveal the pharmacological mechanisms in treating TNBS-induced ulcerative colitis in rats
    Deepa S. Mandlik, Rutuparna Joshi, Chaitanya Kalsekar, Abhishek Kamble, Manoj Magre, Amol Muthal, Satish K. Mandlik, Vaibhav M. Shinde · 2025 · In Silico Pharmacology
  5. Hidden Clues in the Epithelial Brush Border: A New Prognostic Marker for Pediatric Crohn’s Disease
    Chao Li, Matthew A. Ciorba · 2025 · Inflammatory Bowel Diseases
  6. Microbiome-based biomarkers for inflammatory bowel disease diagnosis and prognosis
    Muhammad Zaid Salar, Naila Ghafoor, Ayesha Ghafoor, Atif Amin Baig · 2026 · Elsevier eBooks
  7. Lysosomal autophagy in the treatment of inflammatory bowel disease
    Sruthi Vijaya Retnakumar · 2022 · theses.fr (ABES)
  8. Histologic Activity Modifies the Predictive Value of Systemic Inflammatory Markers in Ulcerative Colitis
    Minjee Kim, Ji Eun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim · 2026 · Diagnostics
  9. Optimising clinical trial design choices in inflammatory bowel disease
    Peter J. Bossuyt, Katarzyna Moscicka, Kremena Stoyanova, Jennifer Zalud, Luke M. Shelton · 2026 · BMJ Open Gastroenterology
  10. Ulcerative colitis, but not Crohn’s disease, displays demographically and clinically driven mucosal immune heterogeneity: implications for patient stratification
    Ángel De Prado, Irene Soleto, Carolina G. de Castro, Montserrat Baldan Martin, Alejandro G. del Hierro, Paula J. Martínez, Elisa Arribas‐Rodríguez, Fabio Suárez‐Trujillo, Aida Fiz‐López, Álvaro Martín‐Muñoz et al. · 2026 · Frontiers in Immunology